Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Circulating cell free DNA during definitive chemo-radiotherapy in non-small cell lung cancer patients – initial observations

PLoS ONE(2020)10.1371/journal.pone.0231884Source: DataRank Database

Circulating cell free DNA during definitive chemo-radiotherapy in non-small cell lung cancer patients – initial observations is a research paper published in PLoS ONE (2020). On theSindex it has a DataRank of 0. It has been cited 19 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access19 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)Impact (FWCI 0.78)OA: goldTopics (85)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (14)

Lise Barlebo Ahlborn ORCID,Gitte Fredberg Persson ORCID,Dineika Chandrananda ORCID,J Langer,Barbara Malene Fischer ORCID

Live enrichment

PubMed:32343749 PMC:PMC7188247 OpenAlex:https://openalex.org/W3018592670

Kræftens Bekæmpelse

Grant: R72-A4605-13-S2

Foundation for the National Institutes of Health

Grant: P30 CA 134274-04

Cancer Research UK

Grant: 11906

Cancer Research UK

Grant: 20240

NCI NIH HHS

Grant: P30 CA134274

Cancer Research UK

Grant: 28292

National Institute for Health Research (NIHR)

Grant: RP-2016-07-001

Cancer Research UK

Grant: 27548

National Institutes of Health

Grant: 2P30CA134274-04

Protocol Specific Research

FWCI

0.78

Citation Percentile

0.6%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0231884&type=printable

publisherhttps://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0231884&type=printable

publisherhttps://dx.plos.org/10.1371/journal.pone.0231884

journalhttps://doi.org/10.1371/journal.pone.0231884

repositoryhttps://pubmed.ncbi.nlm.nih.gov/32343749

Fields of Study

Cancer Genomics and DiagnosticsCancer Cells and MetastasisLung Cancer Treatments and Mutations03 medical and health sciences0302 clinical medicineAdenocarcinomaAgedAged, 80 and overAntineoplastic AgentsCarcinoma, Non-Small-Cell LungCarcinoma, Squamous CellCell-Free Nucleic AcidsChemoradiotherapyFemaleHumansLung NeoplasmsMaleMiddle AgedPilot ProjectsRadiation, IonizingTomography, X-Ray Computed

MeSH Terms

Cell-Free Nucleic AcidsAdenocarcinomaAgedAged, 80 and overAntineoplastic AgentsCarcinoma, Non-Small-Cell LungCarcinoma, Squamous CellFemaleHumansLung NeoplasmsMaleMiddle AgedPilot ProjectsRadiation, IonizingTomography, X-Ray ComputedChemoradiotherapy

Keywords

Radiation therapyLung cancerCell-free fetal DNAMedicineCellCancerOncologyCancer researchInternal medicinePathologyBiologyGeneticsMaleSquamous Cell/drug therapyIonizingLung Neoplasms/geneticsLung NeoplasmsScienceAntineoplastic AgentsPilot ProjectsAdenocarcinomaAdenocarcinoma/drug therapyCarcinoma, Squamous Cell/drug therapyCarcinoma, Non-Small-Cell Lung/geneticsCarcinoma, Non-Small-Cell LungRadiation, Ionizing80 and overHumansTomographyAgedNon-Small-Cell Lung/geneticsMedicine and health sciencesAged, 80 and overRadiationBiology and life sciencesCarcinomaQAntineoplastic Agents/therapeutic useRChemoradiotherapyMiddle AgedX-Ray ComputedCell-Free Nucleic Acids/bloodCarcinoma, Squamous CellFemaleTomography, X-Ray ComputedCell-Free Nucleic AcidsResearch Article

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being